The JAK-Inhibitor Tofacitinib Rescues Human Intestinal Epithelial Cells and Colonoids from Cytokine-Induced Barrier Dysfunction

Sayoc-Becerra, Anica
Krishnan, Moorthy PhD
Fan, Shujun PhD
Jimenez, Jossue
Hernandez, Rebecca
Gibson, Kyle
Preciado, Reyna
Butt, Grant PhD
McCole, Declan F PhD

Division of Biomedical Sciences, School of Medicine, University of California, Riverside, CA, USA
Department of Physiology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand

Address correspondence to: Declan F. McCole, PhD, Division of Biomedical Sciences, School of Medicine, University of California–Riverside, 307 School of Medicine Research Building, 900 University Avenue, Riverside, CA, 92521 USA. E-mail: [email protected].

Received May 02, 2019

Online date: November 21, 2019

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

Inflammatory Bowel Diseases 26(3):p 407-422, February 11, 2020. | DOI: 10.1093/ibd/izz266